Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17758549 | 0.77 | KMT2A (0.44) | ALDH1A1CYP2C9HPGDCYP3A4 | |
| SCHEMBL17758465 | 0.74 | NPC1 (0.46) | ALDH1A1 | |
| SCHEMBL17758492 | 0.71 | EPHX1 (0.43) | ALDH1A1CYP3A4 | |
| SCHEMBL17758480 | 0.71 | ALDH1A1 (0.36) | ALDH1A1CYP2C9HPGDHSD17B10CYP3A4 | |
| SCHEMBL2107954 | 0.71 | — | — | |
| SCHEMBL11608066 | 0.69 | — | — | |
| SCHEMBL7322369 | 0.67 | — | — | |
| SCHEMBL10937561 | 0.67 | ALDH1A1 (0.34) | ALDH1A1HPGDCYP3A4 | |
| SCHEMBL16425174 | 0.67 | KDM4E (0.42) | ALDH1A1CYP3A4 | |
| SCHEMBL6223656 | 0.65 | CYP2C19 (0.39) | ALDH1A1HPGDCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | ALDH1A1 4000/4885CYP2C9 4691/4885HPGD 3778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.